A52T (p.Ala52Thr) variant of JAK2 (Tyrosine-protein kinase JAK2)

A52T (p.Ala52Thr) in JAK2 (Tyrosine-protein kinase JAK2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.34 / 1. The record also includes population frequency data and structural context.

A52T (p.Ala52Thr) variant details